1. Cancer statistics;Siegel;CA Cancer J Clin,2020
2. 2. Planchard D, Popat S, Kerr K, Novello S, Smit EF, Faivre-Finn C, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):192-237.
3. A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study;Lee;J Oncol Pharm Pract,2022
4. Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patients;Inoue;Jpn J Clin Oncol,2016
5. 5. Horn L, Lovely CM. Neoplasms of the Lung. In: Jameson JL (ed). Harrison's Principles of Internal Medicine. 20. United States of America: McGraw Hill Education; 2018;537-52.